A signature of three biomarkers can identify patients with Alzheimer's and may be able to help predict which patients may be at risk of developing the disease, researchers say.
When applying these markers -- beta-amyloid protein 1-42, total tau protein, and phosphorylated tau -- to an established data set, it accurately identified 90% of the group that had Alzheimer's disease, according to Hugo Vanderstichele, PhD, of Innogenetics in Gent, Belgium, and colleagues.
Continue Reading
No comments:
Post a Comment